Cargando…

Zibotentan in systemic sclerosis-associated chronic kidney disease: a phase II randomised placebo-controlled trial

BACKGROUND: We report results from a phase II randomised placebo-controlled trial assessing zibotentan, a highly selective endothelin receptor antagonist (ERA), in chronic kidney disease (CKD) secondary to systemic sclerosis (SSc). METHODS: This trial included three sub-studies: ZEBRA 1—a randomised...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stern, Edward P., Host, Lauren V., Wanjiku, Ivy, Escott, K. Jane, Gilmour, Peter S., Ochiel, Rachel, Unwin, Robert, Burns, Aine, Ong, Voon H., Cadiou, Helen, O’Keeffe, Aidan G., Denton, Christopher P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158153/ https://www.ncbi.nlm.nih.gov/pubmed/35650639 http://dx.doi.org/10.1186/s13075-022-02818-6

Ejemplares similares

Exploring molecular pathology of chronic kidney disease in systemic sclerosis by analysis of urinary and serum proteins
por: Stern, Edward P, et al.
Publicado: (2021)

Pharmacokinetics and Tolerability of Zibotentan in Patients with Concurrent Moderate Renal and Moderate Hepatic Impairment
por: Mercier, Anne-Kristina, et al.
Publicado: (2023)

Rationale and design of the Medical Research Council's Precision Medicine with Zibotentan in Microvascular Angina (PRIZE) trial
por: Morrow, Andrew J, et al.
Publicado: (2020)

Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis
por: Cole, Alice, et al.
Publicado: (2022)

Zibotentan, an Endothelin A Receptor Antagonist, Prevents Amyloid-β-Induced Hypertension and Maintains Cerebral Perfusion
por: Palmer, Jennifer C., et al.
Publicado: (2020)

Systemic sclerosis and COVID-19 vaccines: a SPIN Cohort study
por: Gordon, Jessica K, et al.
Publicado: (2022)

Pharmacokinetics and tolerability of zibotentan (ZD4054) in subjects with hepatic or renal impairment: two open-label comparative studies
por: Tomkinson, Helen, et al.
Publicado: (2011)

Relapsing polychondritis in systemic sclerosis: A rare vasculitic mimic
por: Teles, Carolina, et al.
Publicado: (2023)

Distinctive clinical phenotype of anti-centromere antibody-positive diffuse systemic sclerosis
por: Caetano, Joana, et al.
Publicado: (2018)

The sodium glucose co-transporter 2 inhibitor dapagliflozin ameliorates the fluid-retaining effect of the endothelin A receptor antagonist zibotentan
por: Veenit, Vandana, et al.
Publicado: (2023)

HIV cure trial mergers: Spotlighting the epigenetics of latency reversal
por: Denton, Paul W.
Publicado: (2022)

Challenges and priorities for delivering on the Beijing Declaration and Platform for Action 25 years on
por: Allotey, Pascale, et al.
Publicado: (2020)

Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes
por: Clark, Kristina E. N., et al.
Publicado: (2022)

Diffuse cutaneous systemic sclerosis following SARS-Co V-2 vaccination
por: Cole, Alice, et al.
Publicado: (2022)

Infectious etiology in multiple sclerosis: the debate continues
por: González-Scarano, Francisco, et al.
Publicado: (1999)

The impact of road safety strategy and policy on admissions to a national rehabilitation hospital; a 5-year retrospective review and reflection on trauma data
por: Carroll, Áine, et al.
Publicado: (2023)

Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trial
por: Kalil, Andre C, et al.
Publicado: (2021)

Implications of systemic racism in emergency medical services: On prehospital bias and complicity
por: Ventura, Christian Angelo I., et al.
Publicado: (2022)

Editorial Comments: Is multiple sclerosis a neurodegenerative or inflammatory disease?
por: Korczyn, Amos D.
Publicado: (2013)

Mental health before and during the pandemic in people with systemic sclerosis
por: Henry, Richard S, et al.
Publicado: (2022)

Time to consider elimination of HIV in China
por: Li, Jinghua, et al.
Publicado: (2022)

Comment on Khairul Zaman et al. Eco-Friendly Coagulant versus Industrially Used Coagulants: Identification of Their Coagulation Performance, Mechanism and Optimization in Water Treatment Process. Int. J. Environ. Res. Public Health 2021, 18, 9164
por: Ivy, Afia, et al.
Publicado: (2021)

Dysregulated B cell function and disease pathogenesis in systemic sclerosis
por: Beesley, Claire F., et al.
Publicado: (2023)

The “discordant doppelganger dilemma”: SGLT2i mimics therapeutic carbohydrate restriction - food choice first over pharma?
por: Murray, Scott W., et al.
Publicado: (2021)

Placebos in clinical care: a suggestion beyond the evidence
por: Maher, Christopher G, et al.
Publicado: (2021)

Iloprost for COVID-19-related vasculopathy
por: Moezinia, Carine J, et al.
Publicado: (2020)

Energy restriction in people with multiple sclerosis: Is time more important than calories?
por: Ghezzi, Laura
Publicado: (2022)

Dilated Virchow Robin spaces in multiple sclerosis – a generalised marker of disease?
por: Vivash, Lucy
Publicado: (2023)

Single-cell analysis reveals key differences between early-stage and late-stage systemic sclerosis skin across autoantibody subgroups
por: Clark, Kristina Elizabeth Neergaard, et al.
Publicado: (2023)

Approaches to the Estimation of the Local Average Treatment Effect in a Regression Discontinuity Design
por: O'Keeffe, Aidan G., et al.
Publicado: (2016)

Preventing disease progression in multiple sclerosis—insights from large real-world cohorts
por: Engel, Sinah, et al.
Publicado: (2022)

COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study
por: Ferri, Clodoveo, et al.
Publicado: (2021)

SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis
por: Di Filippo, Massimiliano, et al.
Publicado: (2022)

A complex intervention to improve anxiety in people with systemic sclerosis during COVID-19
por: Newby, Jill M
Publicado: (2021)

“Do Not Mix Apples with Oranges” to Avoid Misinterpretation of Placebo Effects in Manual Therapy: The Risk Is Resulting in a Fruit Basket. Comment on Molina-Àlvarez et al. Manual Therapy Effect in Placebo-Controlled Trials: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health 2022, 19, 14021
por: Rossettini, Giacomo, et al.
Publicado: (2023)

New Insights into Multiple Sclerosis Mechanisms: Lipids on the Track to Control Inflammation and Neurodegeneration
por: Podbielska, Maria, et al.
Publicado: (2021)

Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis
por: Spierings, Julia, et al.
Publicado: (2021)

Ushering in safe, effective, secure, and ethical medicine in the digital era
por: Gordon, William J., et al.
Publicado: (2021)

Artificial intelligence in the medical profession: ready or not, here AI comes
por: Pucchio, Aidan, et al.
Publicado: (2022)

Effect of mycophenolate mofetil dose on antibody response following initial SARS-CoV-2 vaccination in patients with systemic sclerosis
por: Wallwork, Rachel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9bdi7j051jfrcrm02q3s4poo5n